OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Treatment patterns and burden of myelosuppression for patients with small cell lung cancer: A SEER‐medicare study
Robert S. Epstein, Jerrod Nelms, Donald Moran, et al.
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100555-100555
Open Access | Times Cited: 7
Robert S. Epstein, Jerrod Nelms, Donald Moran, et al.
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100555-100555
Open Access | Times Cited: 7
Showing 7 citing articles:
Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices
Lowell L. Hart, Augustina Ogbonnaya, Kristen Boykin, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 10020-10030
Open Access | Times Cited: 9
Lowell L. Hart, Augustina Ogbonnaya, Kristen Boykin, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 10020-10030
Open Access | Times Cited: 9
Cancer nuclear envelope rupture and repair in taxane resistance
Ana P. Xu, Lucy B. Xu, Elizabeth R. Smith, et al.
Medical Review (2024) Vol. 4, Iss. 6, pp. 522-530
Open Access | Times Cited: 1
Ana P. Xu, Lucy B. Xu, Elizabeth R. Smith, et al.
Medical Review (2024) Vol. 4, Iss. 6, pp. 522-530
Open Access | Times Cited: 1
Burden of Chemotherapy-Induced Myelosuppression among Patients with ES-SCLC in US Community Oncology Settings
Jerome H. Goldschmidt, Alisha Monnette, Ping Shi, et al.
Future Oncology (2022) Vol. 18, Iss. 35, pp. 3881-3894
Open Access | Times Cited: 6
Jerome H. Goldschmidt, Alisha Monnette, Ping Shi, et al.
Future Oncology (2022) Vol. 18, Iss. 35, pp. 3881-3894
Open Access | Times Cited: 6
Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer
Yina Gao, Yangyang Dong, Yingxu Zhou, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 5
Yina Gao, Yangyang Dong, Yingxu Zhou, et al.
International Journal of Clinical Practice (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 5
Real-World Outcomes of Trilaciclib Among Patients with Extensive-Stage Small Cell Lung Cancer Receiving Chemotherapy
Jerome H. Goldschmidt, Lowell L. Hart, Jeffrey A. Scott, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4189-4215
Open Access | Times Cited: 2
Jerome H. Goldschmidt, Lowell L. Hart, Jeffrey A. Scott, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4189-4215
Open Access | Times Cited: 2
Construction of an auxiliary scoring model for myelosuppression in patients with lung cancer chemotherapy based on random forest algorithm.
Yingjun Dong, Changqing Hu, Jun Liu, et al.
PubMed (2023) Vol. 15, Iss. 6, pp. 4155-4163
Closed Access
Yingjun Dong, Changqing Hu, Jun Liu, et al.
PubMed (2023) Vol. 15, Iss. 6, pp. 4155-4163
Closed Access
A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection
Prashant Dogra, Carmine Schiavone, Zhihui Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Prashant Dogra, Carmine Schiavone, Zhihui Wang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
